Drug-disease interactions: reduced β-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat-Reference-Cited by-同舟云学术

Drug-disease interactions: reduced β-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat

Published:2001-05 Issue:2 Volume:133 Page:286-294
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Kulmatycki Kenneth M,Abouchehade Kassem,Sattari Saeed,Jamali Fakhreddin

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0704067/fullpdf

Reference43 articles.

1. Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration;ABERNETHY;J. Pharmacol. Exp. Ther.,1993

2. Verapamil pharmacodynamics and disposition in obese hypertensive patients;ABERNETHY;J. Cardiovasc. Pharmacol.,1988

3. Sotalol: an important new antiarrhythmic;ANDERSON;Am. Heart J.,1999

4. Preparation of standards and measurement of nitric oxide, nitroxyl and related oxidation products;ARCHER;Methods Enzymolog.,1995

5. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat;BELPAIRE;Fundam. Clin. Pharmacol.,1989

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empagliflozin significantly prevents QTc prolongation due to amitriptyline intoxication;CARDIOVASC J AFR;2023

2. Estimation of purity of antimicrobial lead compound sulfonamide‐anthranilate derivative methyl‐ester‐toluene‐sulfonamide using LC to develop a new drug application;Biomedical Chromatography;2023-04-30

3. Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition;Journal of Pharmacy & Pharmaceutical Sciences;2023-02-06

4. Animal models to study pathogenesis and treatments of cardiac disorders in rheumatoid arthritis: Advances and challenges for clinical translation;Pharmacological Research;2021-08

5. Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats;Kardiologia Polska;2021-01-25